Drug-induced renal calculi: epidemiology, prevention and management
M Daudon, P Jungers - Drugs, 2004 - Springer
Abstract Drug-induced calculi represent 1–2% of all renal calculi. The drugs reported to
produce calculi formation may be divided into two groups. The first one includes poorly …
produce calculi formation may be divided into two groups. The first one includes poorly …
Urolithiasis with topiramate in nonambulatory children and young adults
M Goyal, RI Grossberg, MA O'Riordan, ID Davis - Pediatric neurology, 2009 - Elsevier
Urolithiasis occurs infrequently in the pediatric population, where metabolic factors play a
primary role in the pathogenesis of stone formation. Topiramate, an antiepileptic drug, is …
primary role in the pathogenesis of stone formation. Topiramate, an antiepileptic drug, is …
Alterações laboratoriais decorrentes do uso do topiramato e comparativo com alterações existentes nas doenças em tratamento: epilepsia, obesidade e transtorno do …
TNF Freitas - 2022 - repositorio.ufrn.br
RESUMO O topiramato (TPM) é um fármaco anticonvulsivante ou antiepilético utilizado na
prevenção de crises epilépticas, além de ser utilizado no tratamento da obesidade e no …
prevenção de crises epilépticas, além de ser utilizado no tratamento da obesidade e no …
Postikale Hyper-CK-Ämie und antiepileptikainduzierte Myopathie bzw. Rhabdomyolyse nicht vergessen!
G Krämer - DGNeurologie, 2021 - Springer
Die sehr schöne Übersicht von Sieb (SOP/Algorithmus) in Heft 1/2021 zu den möglichen
Ursachen einer erhöhen Kreatinkinaseserumaktivität [1] bedarf einer praxisrelevanten …
Ursachen einer erhöhen Kreatinkinaseserumaktivität [1] bedarf einer praxisrelevanten …
[PDF][PDF] 1. Exposure Data
DCASR Nos - Citeseer
H (e) Spectroscopy data: Infrared [prism, 2538], ultraviolet [3.1] and mass spectral data have
been reported (Weast & Astle, 1985; Sadtler Research Laboratories, 1991).(f) Solubility …
been reported (Weast & Astle, 1985; Sadtler Research Laboratories, 1991).(f) Solubility …
[HTML][HTML] Phenytoin
IARC Working Group on the Evaluation of … - Some Pharmaceutical …, 1996 - ncbi.nlm.nih.gov
Phenytoin - Some Pharmaceutical Drugs - NCBI Bookshelf Your browser does not support
the NLM PubReader view. Go to this page to see a list of supported browsers or return to the …
the NLM PubReader view. Go to this page to see a list of supported browsers or return to the …
[引用][C] Subcutaneous immunoglobulin treatment of inclusion‐body myositis stabilizes dysphagia
K Pars, N Garde, T Skripuletz, R Pul, R Dengler… - Muscle & …, 2013 - Wiley Online Library
Inclusion-body myositis (IBM) is an inflammatory muscle disease that leads to atrophic limb
paresis and bulbar dysfunction. 1, 2 Dysphagia affects up to 70% of IBM patients and …
paresis and bulbar dysfunction. 1, 2 Dysphagia affects up to 70% of IBM patients and …
[引用][C] Osteomalacic myopathy: an uncommon side effect of antiepileptic drugs
The association between osteopenia/osteomalacia and enzyme-inducing antiepileptic drugs
(EIAEDs), such as phenobarbital (PB) and carbamazepine (CBZ), is well documented. 1 …
(EIAEDs), such as phenobarbital (PB) and carbamazepine (CBZ), is well documented. 1 …